186 related articles for article (PubMed ID: 1637555)
21. Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications.
Josso N; Picard JY; Rey R; di Clemente N
Pediatr Endocrinol Rev; 2006 Jun; 3(4):347-58. PubMed ID: 16816803
[TBL] [Abstract][Full Text] [Related]
22. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro.
Ueno S; Manganaro TF; Donahoe PK
Endocrinology; 1988 Sep; 123(3):1652-9. PubMed ID: 2456917
[TBL] [Abstract][Full Text] [Related]
23. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
Teixeira J; Maheswaran S; Donahoe PK
Endocr Rev; 2001 Oct; 22(5):657-74. PubMed ID: 11588147
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
[TBL] [Abstract][Full Text] [Related]
25. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.
Rey R; al-Attar L; Louis F; Jaubert F; Barbet P; Nihoul-Fékété C; Chaussain JL; Josso N
Am J Pathol; 1996 May; 148(5):1689-98. PubMed ID: 8623936
[TBL] [Abstract][Full Text] [Related]
26. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
Hirobe S; He WW; Lee MM; Donahoe PK
Endocrinology; 1992 Aug; 131(2):854-62. PubMed ID: 1639028
[TBL] [Abstract][Full Text] [Related]
27. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.
Lee MM; Donahoe PK; Hasegawa T; Silverman B; Crist GB; Best S; Hasegawa Y; Noto RA; Schoenfeld D; MacLaughlin DT
J Clin Endocrinol Metab; 1996 Feb; 81(2):571-6. PubMed ID: 8636269
[TBL] [Abstract][Full Text] [Related]
28. Serum müllerian inhibiting substance assay--a new diagnostic test for disorders of gonadal development.
Forest MG
N Engl J Med; 1997 May; 336(21):1519-21. PubMed ID: 9154774
[No Abstract] [Full Text] [Related]
29. Müllerian inhibiting substance in sex-reversed dogs.
Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
[TBL] [Abstract][Full Text] [Related]
30. Müllerian-inhibiting substance function during mammalian sexual development.
Behringer RR; Finegold MJ; Cate RL
Cell; 1994 Nov; 79(3):415-25. PubMed ID: 7954809
[TBL] [Abstract][Full Text] [Related]
31. Identification of müllerian inhibiting substance specific binding in human cell lines.
MacLaughlin DT; Levin RK; Catlin EA; Taylor LA; Preffer FI; Donahoe PK
Horm Metab Res; 1992 Dec; 24(12):570-5. PubMed ID: 1478615
[TBL] [Abstract][Full Text] [Related]
32. Re: Testicular descent: a proposed interaction between müllerian inhibiting substance and epidermal growth factor.
Barthold JS
J Urol; 1998 Oct; 160(4):1438-40. PubMed ID: 9751382
[No Abstract] [Full Text] [Related]
33. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.
Gustafson ML; Lee MM; Asmundson L; MacLaughlin DT; Donahoe PK
J Pediatr Surg; 1993 Mar; 28(3):439-44. PubMed ID: 8468660
[TBL] [Abstract][Full Text] [Related]
34. Influence of chick or quail embryonic testes on the reproductive system of the quail embryo.
Rogulska T; Klotz AG; Laszczych-Lupinska J
Biol Struct Morphog; 1992; 4(1):23-7. PubMed ID: 1420595
[TBL] [Abstract][Full Text] [Related]
35. Müllerian inhibiting substance production associated with loss of oocytes and testicular differentiation in the transplanted mouse XX gonadal primordium.
Taketo T; Saeed J; Manganaro T; Takahashi M; Donahoe PK
Biol Reprod; 1993 Jul; 49(1):13-23. PubMed ID: 8353178
[TBL] [Abstract][Full Text] [Related]
36. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
[TBL] [Abstract][Full Text] [Related]
37. Sex-specific fetal lung development and müllerian inhibiting substance.
Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase.
Cigarroa FG; Coughlin JP; Donahoe PK; White MF; Uitvlugt N; MacLaughlin DT
Growth Factors; 1989; 1(2):179-91. PubMed ID: 2560399
[TBL] [Abstract][Full Text] [Related]
39. Involution of the female Mullerian duct of the fetal rat in the organ-culture assay for the detection of Mullerian Inhibiting Substance.
Price JM; Donahoe PK; Ito Y
Am J Anat; 1979 Oct; 156(2):265-84. PubMed ID: 506954
[TBL] [Abstract][Full Text] [Related]
40. Mullerian inhibiting substance: a fetal hormone with surgical implications.
Hutson JM; Donahoe PK; Budzik GP
Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
